APA (7th ed.) Citation

Liebers, N., Düll, J., Fitzgerald, D., Kerkhoff, A., Nörenberg, D., Käbisch, E., . . . Dietrich, S. (2021). Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood advances, 5(13), . https://doi.org/10.1182/bloodadvances.2020004155

Chicago Style (17th ed.) Citation

Liebers, Nora, et al. "Polatuzumab Vedotin as a Salvage and Bridging Treatment in Relapsed or Refractory Large B-cell Lymphomas." Blood Advances 5, no. 13 (2021). https://doi.org/10.1182/bloodadvances.2020004155.

MLA (9th ed.) Citation

Liebers, Nora, et al. "Polatuzumab Vedotin as a Salvage and Bridging Treatment in Relapsed or Refractory Large B-cell Lymphomas." Blood Advances, vol. 5, no. 13, 2021, https://doi.org/10.1182/bloodadvances.2020004155.